-
1
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
2
-
-
0023942368
-
Surgery in advanced ovarian carcinoma: Is there proof to show the benefit?
-
Heintz AP: Surgery in advanced ovarian carcinoma: is there proof to show the benefit? Eur J Surg Oncol 14: 91-99, 1988.
-
(1988)
Eur J Surg Oncol
, vol.14
, pp. 91-99
-
-
Heintz, A.P.1
-
3
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
DOI 10.1056/NEJM199601043340101
-
McGuire WP, Hoskins WJ, Brady MF, et al: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334: 1-6, 1996. (Pubitemid 26012496)
-
(1996)
New England Journal of Medicine
, vol.334
, Issue.1
, pp. 1-6
-
-
Mcguire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
Kucera, P.R.4
Partridge, E.E.5
Look, K.Y.6
Clarke-Pearson, D.L.7
Davidson, M.8
-
4
-
-
1542577513
-
A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer
-
Takei Y, Suzuki M, Ohwada M, et al: A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer. Oncol Rep 10: 951-955, 2003.
-
(2003)
Oncol Rep
, vol.10
, pp. 951-955
-
-
Takei, Y.1
Suzuki, M.2
Ohwada, M.3
-
5
-
-
0036852241
-
Cancer immunoediting: From immunosurveillance to tumor escape
-
DOI 10.1038/ni1102-991
-
Dunn GP, Bruce AT, Ikeda H, Old LJ and Schreiber RD: Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991-998, 2002. (Pubitemid 35363648)
-
(2002)
Nature Immunology
, vol.3
, Issue.11
, pp. 991-998
-
-
Dunn, G.P.1
Bruce, A.T.2
Ikeda, H.3
Old, L.J.4
Schreiber, R.D.5
-
6
-
-
79953151458
-
Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion
-
Schreiber RD, Old LJ and Smyth MJ: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331: 1565-1570, 2011.
-
(2011)
Science
, vol.331
, pp. 1565-1570
-
-
Schreiber, R.D.1
Old, L.J.2
Smyth, M.J.3
-
7
-
-
0014089302
-
Enzymic formation of D-kynurenine from D-tryptophan
-
Higuchi K and Hayaishi O: Enzymic formation of D-kynurenine from D-tryptophan. Arch Biochem Biophys 120: 397-403, 1967.
-
(1967)
Arch Biochem Biophys
, vol.120
, pp. 397-403
-
-
Higuchi, K.1
Hayaishi, O.2
-
8
-
-
0014217450
-
Tryptophan pyrrolase of rabbit intestine. D- and L-tryptophan-cleaving enzyme or enzymes
-
Yamamoto S and Hayaishi O: Tryptophan pyrrolase of rabbit intestine. D- and L-tryptophan-cleaving enzyme or enzymes. J Biol Chem 242: 5260-5266, 1967.
-
(1967)
J Biol Chem
, vol.242
, pp. 5260-5266
-
-
Yamamoto, S.1
Hayaishi, O.2
-
9
-
-
0018148373
-
Indoleamine 2,3 dioxygenase. Purfication and some properties
-
Shimizu T, Nomiyama S, Hirata F and Hayaishi O: Indoleamine 2,3-dioxygenase. Purification and some properties. J Biol Chem 253: 4700-4706, 1978. (Pubitemid 8372084)
-
(1978)
Journal of Biological Chemistry
, vol.253
, Issue.13
, pp. 4700-4706
-
-
Shimizu, T.1
Nomiyama, S.2
Hirata, F.3
Hayaishi, O.4
-
10
-
-
0018649875
-
Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection
-
DOI 10.1073/pnas.76.8.4084
-
Yoshida R, Urade Y, Tokuda M and Hayaishi O: Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc Natl Acad Sci USA 76: 4084-4086, 1979. (Pubitemid 9249028)
-
(1979)
Proceedings of the National Academy of Sciences of the United States of America
, vol.76
, Issue.8
, pp. 4084-4086
-
-
Yoshida, R.1
Urade, Y.2
Tokuda, M.3
Hayaishi, O.4
-
12
-
-
0034850590
-
Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism
-
DOI 10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S
-
Fujigaki S, Saito K, Sekikawa K, et al: Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur J Immunol 31: 2313-2318, 2001. (Pubitemid 32785349)
-
(2001)
European Journal of Immunology
, vol.31
, Issue.8
, pp. 2313-2318
-
-
Fujigaki, S.1
Saito, K.2
Sekikawa, K.3
Tone, S.4
Takikawa, O.5
Fujii, H.6
Wada, H.7
Noma, A.8
Seishima, M.9
-
13
-
-
0032555614
-
Prevention of allogeneic fetal rejection by tryptophan catabolism
-
Munn DH, Zhou M, Attwood JT, et al: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193, 1998. (Pubitemid 28406294)
-
(1998)
Science
, vol.281
, Issue.5380
, pp. 1191-1193
-
-
Munn, D.H.1
Zhou, M.2
Attwood, J.T.3
Bondarev, I.4
Conway, S.J.5
Marshall, B.6
Brown, C.7
Mellor, A.L.8
-
14
-
-
33645789813
-
Tryptophan degradation increases with stage in patients with rheumatoid arthritis
-
Schroecksnadel K, Winkler C, Duftner C, Wirleitner B, Schirmer M and Fuchs D: Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol 25: 334-337, 2006.
-
(2006)
Clin Rheumatol
, vol.25
, pp. 334-337
-
-
Schroecksnadel, K.1
Winkler, C.2
Duftner, C.3
Wirleitner, B.4
Schirmer, M.5
Fuchs, D.6
-
15
-
-
0025949160
-
Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS
-
Brown RR, Ozaki Y, Datta SP, Borden EC, Sondel PM and Malone DG: Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol 294: 425-435, 1991.
-
(1991)
Adv Exp Med Biol
, vol.294
, pp. 425-435
-
-
Brown, R.R.1
Ozaki, Y.2
Datta, S.P.3
Borden, E.C.4
Sondel, P.M.5
Malone, D.G.6
-
16
-
-
0018128140
-
Metabolic abnormalities of tryptophan and nicotine acid in patients with rheumatoid arthritis
-
Labadarios D, McKenzie DY, Dickerson JW and Parke DV: Metabolic abnormalities of tryptophan and nicotinic acid in patients with rheumatoid arthritis. Rheumatol Rehabil 17: 227-232, 1978. (Pubitemid 9061301)
-
(1978)
Rheumatology and Rehabilitation
, vol.17
, Issue.4
, pp. 227-232
-
-
Labadarios, D.1
McKenzie, D.Y.2
Dickerson, J.W.T.3
Parke, D.V.4
-
17
-
-
0029088935
-
Inhibition of collagenase and stromelysin gene expression by interferon-gamma in human dermal fibroblasts is mediated in part via induction of tryptophan degradation
-
Varga J, Yufit T and Brown RR: Inhibition of collagenase and stromelysin gene expression by interferon-gamma in human dermal fibroblasts is mediated in part via induction of tryptophan degradation. J Clin Invest 96: 475-481, 1995.
-
(1995)
J Clin Invest
, vol.96
, pp. 475-481
-
-
Varga, J.1
Yufit, T.2
Brown, R.R.3
-
18
-
-
5044220930
-
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
-
DOI 10.1038/nri1457
-
Mellor AL and Munn DH: IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774, 2004. (Pubitemid 39336293)
-
(2004)
Nature Reviews Immunology
, vol.4
, Issue.10
, pp. 762-774
-
-
Mellor, A.L.1
Munn, D.H.2
-
19
-
-
0142137237
-
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
-
DOI 10.1038/nm934
-
Uyttenhove C, Pilotte L, Theate I, et al: Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9: 1269-1274, 2003. (Pubitemid 37279849)
-
(2003)
Nature Medicine
, vol.9
, Issue.10
, pp. 1269-1274
-
-
Uyttenhove, C.1
Pilotte, L.2
Theate, I.3
Stroobant, V.4
Colau, D.5
Parmentier, N.6
Boon, T.7
Van Den, E.B.J.8
-
20
-
-
42449151214
-
Functions of natural killer cells
-
DOI 10.1038/ni1582, PII NI1582
-
Vivier E, Tomasello E, Baratin M, Walzer T and Ugolini S: Functions of natural killer cells. Nat Immunol 9: 503-510, 2008. (Pubitemid 351560519)
-
(2008)
Nature Immunology
, vol.9
, Issue.5
, pp. 503-510
-
-
Vivier, E.1
Tomasello, E.2
Baratin, M.3
Walzer, T.4
Ugolini, S.5
-
21
-
-
42449102990
-
Up on the tightrope: Natural killer cell activation and inhibition
-
Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502, 2008.
-
(2008)
Nat Immunol
, vol.9
, pp. 495-502
-
-
Lanier, L.L.1
-
22
-
-
33750699056
-
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function
-
DOI 10.1182/blood-2006-03-006700
-
Della Chiesa D, Carlomagno S, Frumento G, et al: The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood 108: 4118-4125, 2006. (Pubitemid 44913283)
-
(2006)
Blood
, vol.108
, Issue.13
, pp. 4118-4125
-
-
Della, C.M.1
Carlomagno, S.2
Frumento, G.3
Balsamo, M.4
Cantoni, C.5
Conte, R.6
Moretta, L.7
Moretta, A.8
Vitale, M.9
-
23
-
-
77951938172
-
Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy
-
Inaba T, Ino K, Kajiyama H, et al: Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy. Gynecol Oncol 117: 423-428, 2010.
-
(2010)
Gynecol Oncol
, vol.117
, pp. 423-428
-
-
Inaba, T.1
Ino, K.2
Kajiyama, H.3
-
24
-
-
33845246900
-
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
-
DOI 10.1038/sj.bjc.6603477, PII 6603477
-
Ino K, Yoshida N, Kajiyama H, et al: Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer 95: 1555-1561, 2006. (Pubitemid 44863359)
-
(2006)
British Journal of Cancer
, vol.95
, Issue.11
, pp. 1555-1561
-
-
Ino, K.1
Yoshida, N.2
Kajiyama, H.3
Shibata, K.4
Yamamoto, E.5
Kidokoro, K.6
Takahashi, N.7
Terauchi, M.8
Nawa, A.9
Nomura, S.10
Nagasaka, T.11
Takikawa, O.12
Kikkawa, F.13
-
25
-
-
34548024195
-
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer
-
Takao M, Okamoto A, Nikaido T, et al: Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer. Oncol Rep 17: 1333-1339, 2007.
-
(2007)
Oncol Rep
, vol.17
, pp. 1333-1339
-
-
Takao, M.1
Okamoto, A.2
Nikaido, T.3
-
26
-
-
70349746798
-
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
-
Inaba T, Ino K, Kajiyama H, et al: Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma. Gynecol Oncol 115: 185-192, 2009.
-
(2009)
Gynecol Oncol
, vol.115
, pp. 185-192
-
-
Inaba, T.1
Ino, K.2
Kajiyama, H.3
-
27
-
-
32644452086
-
RNA interference in cancer
-
DOI 10.1016/j.bioeng.2006.01.002, PII S1389034406000037
-
Gartel AL and Kandel ES: RNA interference in cancer. Biomol Eng 23: 17-34, 2006. (Pubitemid 43243836)
-
(2006)
Biomolecular Engineering
, vol.23
, Issue.1
, pp. 17-34
-
-
Gartel, A.L.1
Kandel, E.S.2
-
28
-
-
33847793202
-
Gene silencing by small regulatory RNAs in mammalian cells
-
Scherr M and Eder M: Gene silencing by small regulatory RNAs in mammalian cells. Cell Cycle 6: 444-449, 2007. (Pubitemid 46393448)
-
(2007)
Cell Cycle
, vol.6
, Issue.4
, pp. 444-449
-
-
Scherr, M.1
Eder, M.2
-
29
-
-
0026354639
-
Multiple cis-acting elements are required for RNA polymerase III transcription of the gene encoding H1 RNA, the RNA component of human RNase P
-
Hannon GJ, Chubb A, Maroney PA, Hannon G, Altman S and Nilsen TW: Multiple cis-acting elements are required for RNA polymerase III transcription of the gene encoding H1 RNA, the RNA component of human RNase P. J Biol Chem 266: 22796-22799, 1991. (Pubitemid 21908720)
-
(1991)
Journal of Biological Chemistry
, vol.266
, Issue.34
, pp. 22796-22799
-
-
Hannon, G.J.1
Chubb, A.2
Maroney, P.A.3
Hannon, G.4
Altman, S.5
Nilsen, T.W.6
-
30
-
-
42649125223
-
Vector-based delivery of siRNAs: In vitro and in vivo challenges
-
DOI 10.2741/2943
-
Walchli S and Sioud M: Vector-based delivery of siRNAs: in vitro and in vivo challenges. Front Biosci 13: 3488-3493, 2008. (Pubitemid 351594698)
-
(2008)
Frontiers in Bioscience
, vol.13
, Issue.9
, pp. 3488-3493
-
-
Walchli, S.1
Sioud, M.2
-
32
-
-
0034010658
-
A novel natural killer cell line (KHYG-1) from a patient with aggresive natural killer cell leukemia carrying a p53 point mutation
-
Yagita M, Huang CL, Umehara H, et al: A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 14: 922-930, 2000. (Pubitemid 30235072)
-
(2000)
Leukemia
, vol.14
, Issue.5
, pp. 922-930
-
-
Yagita, M.1
Huang, C.L.2
Umehara, H.3
Matsuo, Y.4
Tabata, R.5
Miyake, M.6
Konaka, Y.7
Takatsuki, K.8
-
33
-
-
0023926018
-
Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon -gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity
-
Takikawa O, Kuroiwa T, Yamazaki F and Kido R: Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 263: 2041-2048, 1988. (Pubitemid 18052167)
-
(1988)
Journal of Biological Chemistry
, vol.263
, Issue.4
, pp. 2041-2048
-
-
Takikawa, O.1
Kuroiwa, T.2
Yamazaki, F.3
Kido, R.4
-
34
-
-
1342342857
-
Strategies for Generation of an siRNA Expression Library Directed Against the Human Genome
-
DOI 10.1089/154545703322617005
-
Miyagishi M and Taira K: Strategies for generation of an siRNA expression library directed against the human genome. Oligonucleotides 13: 325-333, 2003. (Pubitemid 38404817)
-
(2003)
Oligonucleotides
, vol.13
, Issue.5
, pp. 325-333
-
-
Miyagishi, M.1
Taira, K.2
-
35
-
-
78650836834
-
Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killer cell function and angiogenesis promotion
-
Nonaka H, Saga Y, Fujiwara H, et al: Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killer cell function and angiogenesis promotion. Int J Oncol 38: 113-120, 2011.
-
(2011)
Int J Oncol
, vol.38
, pp. 113-120
-
-
Nonaka, H.1
Saga, Y.2
Fujiwara, H.3
-
36
-
-
0026347919
-
1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase
-
Cady SG and Sono M: 1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL- alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL- alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch Biochem Biophys 291: 326-333, 1991.
-
(1991)
Arch Biochem Biophys
, vol.291
, pp. 326-333
-
-
Cady, S.G.1
Sono, M.2
-
37
-
-
16244408626
-
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
-
DOI 10.1038/nm1196
-
Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E and Prendergast GC: Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med 11: 312-319, 2005. (Pubitemid 40460560)
-
(2005)
Nature Medicine
, vol.11
, Issue.3
, pp. 312-319
-
-
Muller, A.J.1
DuHadaway, J.B.2
Donover, P.S.3
Sutanto-Ward, E.4
Prendergast, G.C.5
-
38
-
-
59449103002
-
A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA
-
Yen MC, Lin CC, Chen YL, et al: A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA. Clin Cancer Res 15: 641-649, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 641-649
-
-
Yen, M.C.1
Lin, C.C.2
Chen, Y.L.3
-
39
-
-
36048955035
-
The factors that contribute to the long-term expression of siRNA
-
Oxf
-
Shiota M, Ikeda Y and Wadhwa R: The factors that contribute to the long-term expression of siRNA. Nucleic Acids Symp Ser (Oxf) 2006: 243-244, 2006.
-
(2006)
Nucleic Acids Symp Ser
, vol.243-244
, pp. 2006
-
-
Shiota, M.1
Ikeda, Y.2
Wadhwa, R.3
-
40
-
-
79551575238
-
Multi-stage delivery nano-particle systems for therapeutic applications
-
Serda RE, Godin B, Blanco E, Chiappini C and Ferrari M: Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta 1810: 317-329, 2011.
-
(2011)
Biochim Biophys Acta
, vol.1810
, pp. 317-329
-
-
Serda, R.E.1
Godin, B.2
Blanco, E.3
Chiappini, C.4
Ferrari, M.5
|